Login / Signup

Use of multibiomarker disease activity scores in biosimilarity studies for the treatment of patients with rheumatoid arthritis.

Jonathan KayAmy E BockMuhammad RehmanWuyan ZhangMin ZhangNoriko IikuniDaniel F Alvarez
Published in: RMD open (2022)
NCT02222493 and NCT02480153.
Keyphrases
  • disease activity
  • systemic lupus erythematosus
  • rheumatoid arthritis
  • rheumatoid arthritis patients
  • ankylosing spondylitis
  • juvenile idiopathic arthritis
  • case control
  • replacement therapy